Deutsche Biotech Innovativ (DBI) AG is a listed biotechnology company based in Hennigsdorf near Berlin.
The DBI share (DE000A0Z25L1) is traded over-the-counter on the Düsseldorf Stock Exchange. Since fall 2017, the DBI share has also been listed on the Frankfurt Stock Exchange and the Berlin Stock Exchange.
DBI AG was founded in 2009 as Venetus Beteiligungen AG. The company was renamed Deutsche Biotech Innovativ AG in August 2014.
DBI invests in biotechnology companies that pursue an innovative research and development approach and develop drug candidates with a high unique selling proposition.
Neuendorfstraße 15a, 16761 Hennigsdorf bei Berlin – Germany
Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.